Correlation Analysis between Gut Microbiota and Metabolites in Children with Systemic Lupus Erythematosus

From BugSigDB
Reviewed Marked as Reviewed by Claregrieve1 on 2023-4-14
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
Authors
Wen M, Liu T, Zhao M, Dang X, Feng S, Ding X, Xu Z, Huang X, Lin Q, Xiang W, Li X, He X, He Q
Journal
Journal of immunology research
Year
2021
Systemic lupus erythematosus (SLE) is an autoimmune-mediated diffuse connective tissue disease characterized by immune inflammation with an unclear aetiology and pathogenesis. This work profiled the intestinal flora and faecal metabolome of patients with SLE using 16S RNA sequencing and gas chromatography-mass spectrometry (GC-MS). We identified unchanged alpha diversity and partially altered beta diversity of the intestinal flora. Another important finding was the increase in Proteobacteria and Enterobacteriales and the decrease in Ruminococcaceae among SLE patients. For metabolites, amino acids and short-chain fatty acids were enriched when long-chain fatty acids were downregulated in SLE faecal samples. KEGG analysis showed the significance of the protein digestion and absorption pathway, and association analysis revealed the key role of 3-phenylpropanoic acid and Sphingomonas. Sphingomonas were reported to be less abundant in healthy periodontal sites of SLE patients than in those of HCs, indicating transmission of oral species to the gut. This study contributes to the understanding of the pathogenesis of SLE disease from the perspective of intestinal microorganisms, explains the pathogenesis of SLE, and serves as a basis for exploring potential treatments for the disease.

Experiment 1


Reviewed Marked as Reviewed by Claregrieve1 on 2023-4-14

Curated date: 2023/03/19

Curator: Aiyshaaaa

Revision editor(s): Aiyshaaaa, Claregrieve1

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Systemic lupus erythematosus Disease, Libman-Sacks,disseminated lupus erythematosus,excess LMW-DNA,excess lymphocyte low molecular weight DNA,LIBMAN SACKS DIS,Libman Sacks Disease,Libman-Sacks Disease,lupus,Lupus Erythematosus Disseminatus,Lupus Erythematosus, Systemic,lupus erythematosus, systemic,SLE,SLE - lupus erythematosus, systemic,systemic lupus erythematosus,systemic lupus erythematosus (disease),Systemic lupus erythematosus
Group 0 name Corresponds to the control (unexposed) group for case-control studies
HC
Group 1 name Corresponds to the case (exposed) group for case-control studies
SLE
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Individuals who have been diagnosed with systemic lupus erythematosus (SLE). Systemic lupus erythematosus (SLE) is an autoimmune-mediated diffuse connective tissue disease characterized by immune inflammation with an unclear aetiology and pathogenesis.
Group 0 sample size Number of subjects in the control (unexposed) group
28
Group 1 sample size Number of subjects in the case (exposed) group
33
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4-V5
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2023-4-14

Curated date: 2023/03/20

Curator: Aiyshaaaa

Revision editor(s): Aiyshaaaa

Source: Table 2

Description: The differently abundant species at genus, class, phylum, order and family level in both the groups are listed.

Abundance in Group 1: increased abundance in SLE

NCBI Quality ControlLinks
Alphaproteobacteria
Bacilli
Caulobacteraceae
Caulobacterales
Enterobacterales
Enterobacteriaceae
Escherichia/Shigella sp.
Gammaproteobacteria
Hungatella
Klebsiella
Kluyvera
Lachnoclostridium
Lactobacillales
Pseudomonadota
Rhodanobacteraceae
Rudaea
Sphingomonadaceae
Sphingomonadales
Sphingomonas
Streptococcaceae
Streptococcus
Thomasclavelia
Lysobacterales
[Clostridium] innocuum
Mediterraneibacter gnavus

Revision editor(s): Aiyshaaaa

Signature 2

Reviewed Marked as Reviewed by Claregrieve1 on 2023-4-14

Curated date: 2023/03/20

Curator: Aiyshaaaa

Revision editor(s): Aiyshaaaa

Source: Table 2

Description: The differently abundant species at genus, class, phylum, order and family level in both the groups are listed in this table.

Abundance in Group 1: decreased abundance in SLE

NCBI Quality ControlLinks
Agathobacter
Akkermansia
Akkermansiaceae
Christensenellaceae
Dialister
Dorea
Eubacterium coprostanoligenes
Faecalibacterium
Fusicatenibacter
Lachnospiraceae bacterium NC2004
Lachnospiraceae bacterium NK4A136
Odoribacter
Oscillospiraceae
Subdoligranulum
Lachnospira eligens

Revision editor(s): Aiyshaaaa